Palvella Therapeutics, Inc.
PVLA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001583648
In the last 90 days, Palvella Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 196 institutions reported holding it in 13F filings for Q2 2026, worth $2.15B in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Palvella Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- +8 vs. Q3 2024
- Shares held
- 4.03M
- +3.43M (+566.0%) vs. Q3 2024
- Total value
- $48.4M
- +$38.3M (+379.9%) vs. Q3 2024
- New holders
- 11
- 3 more added
- Sold out
- 3
- 6 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PVLA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 196 | $2.15B |
| Q1 2026 | 180 | $1.64B |
| Q4 2025 | 140 | $1.02B |
| Q3 2025 | 100 | $534.5M |
| Q2 2025 | 67 | $133.2M |
| Q1 2025 | 41 | $143.4M |
| Q4 2024 | 33 | $48.4M |
| Q3 2024 | 25 | $10.1M |
| Q2 2024 | 20 | $3.57M |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Palvella Therapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Suvretta Capital Management, LLC | 714,463 | $8.57M | 0.32% | +714,463 | New |
| BVF Inc | 696,555 | $8.36M | 0.28% | +438,929+170.4% | Added |
| Samsara BioCapital, LLC | 679,486 | $8.15M | 1.12% | +679,486 | New |
| Frazier Life Sciences Management, L.P. | 653,892 | $7.85M | 0.33% | +637,950+4,001.7% | Added |
| Adams Street Partners LLC | 409,666 | $4.92M | 4.36% | +409,666 | New |
| Nantahala Capital Management, LLC | 250,062 | $3.00M | 0.21% | +250,062 | New |
| Blue Owl Capital Holdings LP | 250,062 | $3.00M | 0.71% | +250,062 | New |
| ADAR1 Capital Management, LLC | 144,641 | $1.74M | 0.36% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 71,452 | $857.4K | 0.22% | +71,452 | New |
| BML Capital Management, LLC | 42,130 | $505.6K | 0.31% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 21,371 | $256.5K | 0.00% | −10,800−33.6% | Reduced |
| Cresset Asset Management, LLC | 20,911 | $250.9K | 0.00% | +20,911 | New |
| Toronto Dominion Bank | 13,211 | $179.7K | 0.00% | +13,211 | New |
| Geode Capital Management, LLC | 14,270 | $171.3K | 0.00% | +2,289+19.1% | Added |
| BlackRock, Inc. | 12,938 | $155.3K | 0.00% | 00.0% | Unchanged |
| Deltec Asset Management LLC | 12,500 | $150.0K | 0.03% | +12,500 | New |
| Vanguard Group Inc | 11,342 | $136.1K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 10,408 | $124.9K | 0.00% | −1,278−10.9% | Reduced |
| Acadian Asset Management LLC | 1,549 | $18.0K | 0.00% | −1,464−48.6% | Reduced |
| Citigroup Inc | 1,108 | $13.3K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 312 | $3.74K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 202 | $2.42K | 0.00% | −146−42.0% | Reduced |
| Tower Research Capital LLC (TRC) | 175 | $2.10K | 0.00% | +175 | New |
| US Bancorp | 138 | $1.66K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 91 | $1.09K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 63 | $756 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 50 | $600 | 0.00% | −10−16.7% | Reduced |
| JPMorgan Chase & Co | 26 | $312 | 0.00% | 00.0% | Unchanged |
| Truvestments Capital LLC | 14 | $168 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 12 | $144 | 0.00% | −1−7.7% | Reduced |
| Advisor Group Holdings, Inc. | 7 | $84 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 5 | $66 | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 3 | $36 | 0.00% | +3 | New |
| Lynx1 Capital Management LP | 0 | $0 | 0.00% | −37,436−100.0% | Sold out |
| CM Management, LLC | 0 | $0 | 0.00% | −22,500−100.0% | Sold out |
| Danske Bank A/S | 0 | $0 | 0.00% | −2−100.0% | Sold out |